Answer
Zanubrutinib (Brukinsa) has no or negligible influence on driving or using machines, but reported fatigue, dizziness and asthenia should be considered when assessing a patient's ability to do so.
Sources for this answer
- BRUKINSA 80 mg hard capsulesBeOne Medicines UK, Ltd. · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 8Document updated
Sources checked